A Randomised Study to Compare the Effect of the Luteinising Hormone Releasing Hormone (LHRH) Analogue Goserelin With or Without Tamoxifen in Pre- and Perimenopausal Patients With Advanced Breast Cancer

Author： Jonat W.   Kaufmann M.   Blamey R.W.   Howell A.   Collins J.P.   Coates A.   Eiermann W.   Janicke F.   Njordenskold B.   Forbes J.F.   Kolvenbag G.J.C.M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.2, 1995-01, pp. : 137-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women

By Robertson J.F.R.   Blamey R.W.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 861-869

Elsevier

Access to resources Recommend Favorite

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

By                      

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1707-1713

Spandidos Publications

Access to resources Recommend Favorite

Effects of the luteinising hormone-releasing hormone (LH-RH) agonist leuprolide on adenylyl cyclase regulation through G-protein coupled receptors in rat ventral prostate

By Salvador A.   Garca-Paramio M.P.   Sanchez-Chapado M.   Carmena M.J.   Prieto J.C.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 641-648

Elsevier

Access to resources Recommend Favorite

Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system

By Gumlnthert Andreas R.   Grumlndker Carsten   Bongertz Till   Nagy Attila   Schally Andrew V.   Emons Gumlnter  

Breast Cancer Research and Treatment, Vol. 87, Iss. 3, 2004-10 ,pp. : 255-264

Springer Publishing Company

Access to resources Recommend Favorite

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

By Sverrisdottir Asgerdur  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 755-763

Springer Publishing Company

Access to resources Recommend Favorite